about
Physical activity for lower urinary tract symptoms secondary to benign prostatic obstruction5-alpha-reductase inhibitors for lower urinary tract symptoms secondary to benign prostatic obstructionCinnamomi Cortex (Cinnamomum verum) Suppresses Testosterone-induced Benign Prostatic Hyperplasia by Regulating 5α-reductase.Persistent erectile dysfunction in men exposed to the 5α-reductase inhibitors, finasteride, or dutasteride.The New England Research Institutes, Inc. (NERI) Nocturia Advisory Conference 2012: focus on outcomes of therapy.Pharmacologic Therapy in Men's Health: Hypogonadism, Erectile Dysfunction, and Benign Prostatic Hyperplasia.Comparative Effectiveness of Newer Medications for Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: A Systematic Review and Meta-analysis.Long-term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention Trial.Effect of dutasteride on clinical progression of benign prostatic hyperplasia in asymptomatic men with enlarged prostate: a post hoc analysis of the REDUCE study.Patterns of finasteride use in the male populations of four Nordic countries: A cross-national drug utilization study.Treatment of lower urinary tract symptoms in benign prostatic hypertrophy with α-blockers.The role of transurethral resection of the prostate for patients with an elevated prostate-specific antigen.The traditional Korean herbal medicine Ga-Gam-Nai-Go-Hyan suppresses testosterone-induced benign prostatic hyperplasia by regulating inflammatory responses and apoptosis.Vanillic acid attenuates testosterone-induced benign prostatic hyperplasia in rats and inhibits proliferation of prostatic epithelial cells.Characteristics of Men Who Report Persistent Sexual Symptoms After Finasteride Use for Hair Loss.Early-onset baldness and the risk of aggressive prostate cancer: findings from a case-control study.
P2860
Q24186736-09099711-6EBE-4D81-9BEB-0E6AAA23C95FQ24188312-4418D9E9-634B-484D-84BC-DA3F9E532870Q37195621-694B4705-91B2-40F3-80B1-E7F9F2C727B9Q37694089-8A776E8D-AC35-42B1-A1F8-F8FF36A13976Q38077543-CFE37377-F063-4EC3-BB86-2AE03C0426C4Q38846845-0616404E-FB25-46E0-9F29-C2A3E33BCEFDQ38975318-534D4C81-A20F-4707-8CCC-706EF91E2F34Q39168087-4FCBFF44-795C-41D0-80C0-5ECF36A0D8F8Q39844699-58C1E662-0DA0-4FF2-8336-3DB3164A5C3AQ39978732-E5F0C4F2-47B2-42FE-97B4-DB788CC0FE4CQ41092813-AA1B3F23-9526-488A-B4AE-0B68467B8CF7Q42033061-3EF23774-48DE-4392-B650-468C43D43B82Q42059249-CFE918FB-462D-4847-8B80-6FA0BD150F52Q43892537-9DD03893-50B3-4E87-95E9-DA4A6E182D5DQ48040556-1B38FEF3-C621-4B05-93DC-B1C3144C334AQ50012629-1598DB84-6D13-4B95-848E-A60EC45ACC81
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Finasteride for benign prostatic hyperplasia
@ast
Finasteride for benign prostatic hyperplasia
@en
Finasteride for benign prostatic hyperplasia
@en-gb
Finasteride for benign prostatic hyperplasia
@nl
type
label
Finasteride for benign prostatic hyperplasia
@ast
Finasteride for benign prostatic hyperplasia
@en
Finasteride for benign prostatic hyperplasia
@en-gb
Finasteride for benign prostatic hyperplasia
@nl
prefLabel
Finasteride for benign prostatic hyperplasia
@ast
Finasteride for benign prostatic hyperplasia
@en
Finasteride for benign prostatic hyperplasia
@en-gb
Finasteride for benign prostatic hyperplasia
@nl
P2093
P2860
P3181
P1476
Finasteride for benign prostatic hyperplasia
@en
P2093
Howard A Fink
Indy Rutks
James Tacklind
Roderick MacDonald
Timothy J Wilt
P2860
P3181
P356
10.1002/14651858.CD006015.PUB3
P577
2010-10-06T00:00:00Z